We are live on ! Find out more
RTM

Red Tree Management Portfolio holdings

AUM $147M
1-Year Est. Return 202.18%
This Fund
S&P 500
This Quarter Est. Return
-15.96%
1 Year Est. Return
+202.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
–
Cap. Flow
+$174M
Cap. Flow %
114.71%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BCAX
Bicara Therapeutics
BCAX
+$66M
2
CBLL
CeriBell Inc
CBLL
+$60.1M
3
CRGX
CARGO Therapeutics
CRGX
+$38.1M
4
CTNM
Contineum Therapeutics
CTNM
+$10.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLL
1
CeriBell Inc
CBLL
$673M
$57.1M 37.57%
+2,205,661
New +$60.1M
BCAX
2
Bicara Therapeutics
BCAX
$1.7B
$55.2M 36.35%
+3,170,509
New +$66M
CRGX
3
DELISTED
CARGO Therapeutics
CRGX
$30.3M 19.94%
+2,100,732
New +$38.1M
CTNM
4
Contineum Therapeutics
CTNM
$538M
$9.35M 6.15%
+638,158
New +$10.1M

Similar funds

SF
Strategent Financial Harrisonburg, Virginia $147M AUM 14.47% 1-Year Est. Return
EW
Entruity Wealth Bakersfield, California $147M AUM 22.37% 1-Year Est. Return
PWAM
Pinnacle West Asset Management Casper, Wyoming $147M AUM 22.22% 1-Year Est. Return
KFS
Krane Financial Solutions Calabasas, California $147M AUM
SFP
SwitchPoint Financial Planning Lehi, Utah $147M AUM 21.66% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
PIP
Philadelphia Investment Partners Voorhees, New Jersey $147M AUM
NLA
Northern Lights Advisors Seattle, Washington $148M AUM

Red Tree Management's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Red Tree Management, which disclosed 4 positions worth $152M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Bicara Therapeutics: 3,170,509 shares worth $55.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Red Tree Management's largest Q4 2024 buy was Bicara Therapeutics: 3,170,509 shares worth $55.2M.
  • Red Tree Management's ten largest holdings make up 100% of its $152M portfolio in Q4 2024.
  • Red Tree Management disclosed 4 positions in Q4 2024, its first 13F filing on record.

Based on Red Tree Management's 13F filing for Q4 2024, filed 14 Feb 2025.